Works matching IS 10837159 AND DT 2015 AND VI 20 AND IP 8


Results: 22
    1
    2
    3

    In Reply.

    Published in:
    Oncologist, 2015, v. 20, n. 8, p. e25, doi. 10.1634/theoncologist.2015-0157
    By:
    • Peled, Nir
    Publication type:
    Article
    4
    5
    6
    7
    8

    Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers.

    Published in:
    Oncologist, 2015, v. 20, n. 8, p. 907, doi. 10.1634/theoncologist.2014-0294
    By:
    • Shaib, Walid L.;
    • Martin, Ludmila Katherine;
    • Choi, Minsing;
    • Chen, Zhengjia;
    • Krishna, Kavya;
    • Kim, Sungjin;
    • Brutcher, Edith;
    • Staley, Charles;
    • Maithel, Shishir K.;
    • Philip, Philip;
    • Abdel‐Misih, Sherif;
    • Bekaii‐Saab, Tanios S.;
    • El‐Rayes, Bassel F.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.

    Published in:
    Oncologist, 2015, v. 20, n. 8, p. 880, doi. 10.1634/theoncologist.2015-0020
    By:
    • Lambertini, Matteo;
    • Ferreira, Arlindo R.;
    • Poggio, Francesca;
    • Puglisi, Fabio;
    • Bernardo, Antonio;
    • Montemurro, Filippo;
    • Poletto, Elena;
    • Pozzi, Emma;
    • Rossi, Valentina;
    • Risi, Emanuela;
    • Lai, Antonella;
    • Zanardi, Elisa;
    • Sini, Valentina;
    • Ziliani, Serena;
    • Minuti, Gabriele;
    • Mura, Silvia;
    • Grasso, Donatella;
    • Fontana, Andrea;
    • Del Mastro, Lucia
    Publication type:
    Article
    19
    20

    Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH Study.

    Published in:
    Oncologist, 2015, v. 20, n. 8, p. 873, doi. 10.1634/theoncologist.2014-0467
    By:
    • Gligorov, Joseph;
    • Pivot, Xavier B.;
    • Jacot, William;
    • Naman, Hervé L.;
    • Spaeth, Dominique;
    • Misset, Jean‐Louis;
    • Largillier, Rémy;
    • Sautiere, Jean‐Loup;
    • Roquancourt, Anne;
    • Pomel, Christophe;
    • Rouanet, Philippe;
    • Rouzier, Roman;
    • Penault‐Llorca, Frederique M.
    Publication type:
    Article
    21
    22

    Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.

    Published in:
    Oncologist, 2015, v. 20, n. 8, p. 967, doi. 10.1634/theoncologist.2015-0058
    By:
    • Arrieta, Oscar;
    • De la Torre‐Vallejo, Martha;
    • López‐Macías, Diego;
    • Orta, David;
    • Turcott, Jenny;
    • Macedo‐Pérez, Eleazar‐Omar;
    • Sánchez‐Lara, Karla;
    • Ramírez‐Tirado, Laura‐Alejandra;
    • Baracos, Vickie E.
    Publication type:
    Article